Kalyanam Shivkumar MD, PhD, FHRS, FACC
Professor of Medicine & Radiology, Director, UCLA Cardiac Arrhythmia Center & Interventional CV Programs, David Geffen School of Medicine at UCLA, UCLA Health System, Los Angeles, CADr. Shivkumar serves as the director of the created UCLA Cardiac Arrhythmia Center & EP Programs. His field of specialization is interventional cardiac electrophysiology and he heads a group at UCLA that is involved in providing state of the art care, developing innovative techniques for the non-pharmacological management of cardiac arrhythmias with a major focus on cardiac neurobiology research. Dr. Shivkumar’s research work relates to mechanisms of cardiac arrhythmias in humans including the role of the autonomic nervous system in arrhythmias.
The UCLA Neurocardiology Research Center of Excellence was established as the research arm of the Arrhythmia Center in 2014 and has three dedicated full-time scientists as core faculty members. His group is actively involved in human mechanistic studies, development of new IP and medical technology for cardiovascular therapeutics. He serves as Associate editor of Trends in CV Medicine, and is on the editorial board of the journals Heart Rhythm, PACE, JACC Clinical EP, IPEJ and is a peer reviewer for several basic science and clinical journals in cardiology. He also serves as a peer reviewer for the NIH inevaluatingcardiac arrhythmia research. His research work was made possible by grant support from the American Heart Association (1998), the Doris Duke Foundation (2001) and subsequently by the NIH since 2006.
Disclosures
KS is supported by NHLBI P01- HL164311 & Leducq Foundation. KS has developed IP relating to cardiac neural control (assigned to UCLA) and is a co-founder of NeuCures Inc.
Recent Contributions to PracticeUpdate:
- Electrical Storm Treatment by Percutaneous Stellate Ganglion Block
- Nuclear Imaging of the Cardiac Sympathetic Nervous System
- Differences in Risk of Sudden Cardiac Death Between Blacks and Whites
- Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation
- Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation
- 2016 AHA/ACC Clinical Performance and Quality Measures for the Prevention of Sudden Cardiac Death
- MY APPROACH to Selecting Patients for Videoscopic Cardiac Sympathetic Denervation (CSD)
- Strategies to Improve Survival From Cardiac Arrest
- Obesity-Related Risk for Sudden Cardiac Death in the Atherosclerosis Risk in Communities Study